For information on our biotechnology and pharmaceutical capability, please contact Stephen Taylor.

For information on our China capability, please contact Simon Maguire.

[Biotechnology] [Pharmaceutical] [China]

Genemedix

Interferon production facility
Shanghai, China

[Syringes]

CEL’s brief was to undertake a major upgrading of an existing facility to bring it up to European biopharmaceutical standards.

CEL responsibilities

  • Feasibility study
  • Project management
  • Validation

Key features

  • European pharmaceutical standards
  • Cost-effective solutions

Return to our biotechnology project experience.

Return to our biotechnology capability.

Return to our pharmaceutical project experience.

Return to our pharmaceutical capability.

Return to our China project experience.

Return to our China capability.